Liver cell models in in vitro toxicology

被引:303
|
作者
Guillouzo, A [1 ]
机构
[1] Fac Pharm, INSERM, U456, Unite Detoxicat & Reparat Tussulaire, F-35043 Rennes, France
关键词
in vitro liver models; primary cultures; in vitro toxicology; xenobiotic metabolism; human hepatocytes; animal hepatocytes; cytotoxicity; genotoxicity; screening; mechanism of toxicity;
D O I
10.2307/3433803
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
in vitro liver preparations are increasingly used for the study of hepatotoxicity of chemicals, in recent years their actual advantages and limitations have been better defined. The cell models, slices, and mainly primary hepatocyte cultures, appear to be the most powerful in vitro systems, as liver-specific functions and responsiveness to inducers are retained either for a few days or several weeks depending on culture conditions. Maintenance of phase I and phase II xenobiotic metabolizing enzyme activities allows various chemical investigations to be performed, including determination of kinetic parameters, metabolic profile, interspecies comparison, inhibition and induction effects, and drug-drug interactions. in vitro liver cell models also have various applications in toxicology: screening of cytotoxic and genotoxic compounds, evaluation of chemoprotective agents, and determination of characteristic liver lesions and associated biochemical mechanisms induced by toxic compounds. Extrapolation of the results to the in vivo situation remains a matter of debate. Presently, the most convincing applications of liver cell models are the studies on different aspects of metabolism and mechanisms of toxicity. For the future, there is a need for better culture conditions and differentiated hepatocyte cell lines to overcome the limited availability of human liver tissues. In addition, strategies for in vitro analysis of potentially toxic chemicals must be better defined.
引用
收藏
页码:511 / 532
页数:22
相关论文
共 50 条
  • [1] Stem cell models as an in vitro model for predictive toxicology
    Lynch, Stephen
    Pridgeon, Chris S.
    Duckworth, Carrie A.
    Sharma, Parveen
    Park, B. Kevin
    Goldring, Chris E. P.
    BIOCHEMICAL JOURNAL, 2019, 476 : 1149 - 1158
  • [2] Stem Cell Toxicology: Ethical and Epistemic Constraints on In Vitro Models
    Fisher, Grant
    HYLE, 2021, 27 (01): : 67 - 89
  • [3] In-depth xenobiotic metabolism characterization of human in vitro liver models for toxicology
    Pozo, V.
    Cobanoglu, T. Su
    Hammer, H.
    Carlota, R.
    Holm, K.
    Verfaillie, C.
    Poetz, O.
    Jennings, P.
    Moco, S.
    TOXICOLOGY LETTERS, 2024, 399 : S198 - S198
  • [4] New Alternative Models for In Vitro Toxicology
    Caloni, Francesca
    Meloni, Marisa
    Sambuy, Yula
    Alloisio, Susanna
    Mazzoleni, Giovanna
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2016, 33 (04) : 470 - 471
  • [5] Employment of Genetic Selection to the Implementation of Stem Cell Based In Vitro Models for Toxicology
    Jagtap, S.
    Meganathan, K.
    Wagh, V.
    Hescheler, J.
    Sachinidis, A.
    TISSUE ENGINEERING PART A, 2009, 15 (03) : 690 - 690
  • [6] Cell sources for in vitro human liver cell culture models
    Zeilinger, Katrin
    Freyer, Nora
    Damm, Georg
    Seehofer, Daniel
    Knoespel, Fanny
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (15) : 1684 - 1698
  • [7] In vitro models for the investigation of reproductive toxicology in the testis
    Cooke, BA
    REPRODUCTIVE TOXICOLOGY: IN VITRO GERM CELL DEVELOPMENTAL TOXICOLOGY, FROM SCIENCE TO SOCIAL AND INDUSTRIAL DEMAND, 1998, 444 : 95 - 103
  • [8] In Vitro Data and In Silico Models for Computational Toxicology
    Knudsen, T. B.
    BIRTH DEFECTS RESEARCH, 2017, 109 (09): : 649 - 649
  • [9] The fourteenth congress on in vitro toxicology of the Scandinavian Society for Cell Toxicology
    Ekwall, B
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1997, 25 (03): : 253 - 253
  • [10] New cell culture models for in vitro toxicology from bovine and porcine colon epithelium
    Weber, S
    Birkner, S
    Föllmann, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R154 - R154